Altamira Therapeutics CYTOF
OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Altamira Therapeutics Ltd. (CYTOF) Operating Leases (2021 - 2025)

Updated

Altamira Therapeutics' Operating Leases came in at $198,762 for Q2 2025, down 34.6% from $304,053 a year earlier.

Analysis

Altamira Therapeutics Ltd. (CYTOF) Operating Leases (2021 - 2025) Analysis & Trends

At the end of FY2024, Altamira Therapeutics' Operating Leases was $238,691.

  • Operating Leases carries a three-year compound annual growth rate of -21.9% (FY2021 to FY2024).
  • Going back by year, Operating Leases was $356,694 in FY2022 (-28.7%) and $500,481 in FY2021.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 198,762.00
Dec 31, 2024 238,691.00
Jun 30, 2024 304,053.00
Jun 30, 2023 320,092.52
Jan 1, 2023 371,451.00
Dec 31, 2022 372,356.28
Jun 30, 2022 422,367.88
Dec 31, 2021 505,072.81
API Access

Altamira Therapeutics Ltd. Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CYTOF&period=max&api_key=YOUR_API_KEY